IP15: Benign Prostatic Hyperplasia: Epidemiology, Evaluation & Medical Non-surgical Therapy
Friday, May 15, 2026 1:00 PM to 3:00 PM · 2 hr. (America/New_York)
146B
Poster and Podium Sessions
BPH
Friday, May 15
IP15-01: EasyVoid: A Novel Portable Uroflowmeter for Home-Based, Container-Free Urinary Flow Testing on Any Toilet
Friday, May 15, 2026 1:00 PM to 3:00 PM
146B
IP15-02: Nocturnal Bladder Capacity Index Assessment To Improve Nocturia Management In Patients With Lower Urinary Tract Symptoms Related To Benign Prostatic Hyperplasia
Friday, May 15, 2026 1:00 PM to 3:00 PM
146B
Manfredi Bruno Sequi
IP15-03: Perceptions of Ejaculation Among Patients Presenting to Urology Clinic for Lower Urinary Tract Symptoms
Friday, May 15, 2026 1:00 PM to 3:00 PM
146B
IP15-04: The LURN SI-10 Questionnaire: A Valid and Clinically Meaningful Tool That Extends the IPSS in LUTS Assessment
Friday, May 15, 2026 1:00 PM to 3:00 PM
146B
IP15-05: From IPSS to LURN SI-10: Empiric Cutoffs Aligning Mild/Moderate/Severe BPH Symptoms Using 6,382 Same-Day Assessments
Friday, May 15, 2026 1:00 PM to 3:00 PM
146B
IP15-06: Prostate Transition Zone Stiffness Measured by Ultrasound Shear Wave Elastography Varies Across Clinical BPH/LUTS Phenotypes: A Feasibility Study
Friday, May 15, 2026 1:00 PM to 3:00 PM
146B
IP15-07: Relationship Between Prostate MRI Morphology and Lower Urinary Tract Symptoms
Friday, May 15, 2026 1:00 PM to 3:00 PM
146B
IP15-08: The microscopic structural changes of prostate reflected by the apparent diffusion coefficient value affect lower urinary tract function
Friday, May 15, 2026 1:00 PM to 3:00 PM
146B
IP15-09: PSA Kinetics Following Benign Prostate Biopsy: Temporal Patterns and Clinical Implications
Friday, May 15, 2026 1:00 PM to 3:00 PM
146B
IP15-10: Comprehensive identification of factors associated with worsening male lower urinary tract symptoms via meta-16S analysis using a large human gut microbiota database
Friday, May 15, 2026 1:00 PM to 3:00 PM
146B
IP15-11: Tissue-Level Evidence of Microplastics in Benign Prostatic Hyperplasia
Friday, May 15, 2026 1:00 PM to 3:00 PM
146B
IP15-12: Spatial transcriptomic reveals stromal heterogeneity and SRD5A2-independent metabolic niches underlying 5ARI resistance in BPH
Friday, May 15, 2026 1:00 PM to 3:00 PM
146B
IP15-13: MMP7-Triggered Mitophagy via Regulating Parkin-Mediated Ubiquitination of VDAC1 Conferred Anoikis Resistance in the Epithelium of Hyperplastic Prostate
Friday, May 15, 2026 1:00 PM to 3:00 PM
146B
IP15-14: Distinct SRD5A2-reduced Subtypes of Benign Prostatic Hyperplasia Exhibit p-AMPK/Rab9a/PLIN3-Mediated Lipophagic Compensation for Androgen Signaling Defects
Friday, May 15, 2026 1:00 PM to 3:00 PM
146B
ZHEMIN LIN · Beijing Shijitan Hospital
IP15-15: Revisit embryonic reawakening in BPH through Hayflick analysis of prostatic stromal cells
Friday, May 15, 2026 1:00 PM to 3:00 PM
146B
IP15-16: Prostate-Specific Plasma Proteomic Aging Clocks for Disease Prediction
Friday, May 15, 2026 1:00 PM to 3:00 PM
146B
IP15-17: Stem-like Prostate Remodeling in Obesity Mediates Resistance to 5a-Reductase Inhibition Therapy in BPH
Friday, May 15, 2026 1:00 PM to 3:00 PM
146B
IP15-18: RETHINKING LONG-TERM MONITORING OF BENIGN PROSTATIC HYPERPLASIA: DOES SERIAL UROFLOWMETRY PREDICT CLINICAL PROGRESSION?
Friday, May 15, 2026 1:00 PM to 3:00 PM
146B
IP15-19: Association Between Glucagon-Like Peptide-1 Agonist Use and Escalation to Surgical Treatment for Benign Prostatic Hyperplasia: A Nationwide Claims Database Study
Friday, May 15, 2026 1:00 PM to 3:00 PM
146B
IP15-20: Efficacy and safety of vibegron in men =75 years of age with symptoms of overactive bladder on pharmacotherapy for benign prostatic hyperplasia: a subgroup analysis of the COURAGE trial
Friday, May 15, 2026 1:00 PM to 3:00 PM
146B
IP15-21: The Association of Finasteride for Benign Prostatic Hyperplasia with Development of Male Breast Cancer in the United States: A Retrospective Cohort Study of TriNetX Database
Friday, May 15, 2026 1:00 PM to 3:00 PM
146B
IP15-22: Lenalidomide: an antifibrotic reduces outpatient visits related to Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia
Friday, May 15, 2026 1:00 PM to 3:00 PM
146B
IP15-23: Does Benign Prostatic Hyperplasia Affect the Risk of Repeat TURBT?
Friday, May 15, 2026 1:00 PM to 3:00 PM
146B
IP15-24: INCIDENCE AND PREDICTORS OF THE COMPLICATIONS OF CATHETER-DEPENDENT BENIGN PROSTATIC HYPERPLASIA WAIT-TIMES: A MULTI-CENTRE RETROSPECTIVE STUDY
Friday, May 15, 2026 1:00 PM to 3:00 PM
146B
IP15-25: Total sleep duration and rapid eye movement sleep following surgical intervention for benign prostatic hyperplasia: a comparative analysis using wearable device data
Friday, May 15, 2026 1:00 PM to 3:00 PM
146B
IP15-26: Cost-Effectiveness of Surgical Options for Large Gland BPH depends on Patient Priorities: A Comparison of HoLEP, Aquablation, and Simple Prostatectomy
Friday, May 15, 2026 1:00 PM to 3:00 PM
146B
IP15-27: High Patient Adherence to Smartphone-Based Home Uroflowmetry: Real-World Evidence from a Large Commercial Database
Friday, May 15, 2026 1:00 PM to 3:00 PM
146B